Table of Contents
September 15, 2023; Volume 20,Issue 9
C
Chen, Jia
- You have accessLiquid-liquid phase separation in DNA double-strand break repairJia Chen, Jie Shi, Jian Zheng, Yunlong Wang and Xiangbo WanCancer Biology & Medicine September 2023, 20 (9) 627-632; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0252
Chen, Ping
- You have accessThe inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancerXiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping ChenCancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033
Chen, Zhiyu
- You have accessComparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trialXiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian GuoCancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112
D
Ding, Yuwei
- You have accessCSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practiceMengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan WengCancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211
G
Guo, Weijian
- You have accessComparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trialXiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian GuoCancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112
H
He, Min
- You have accessThe inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancerXiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping ChenCancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033
He, Wei
- You have accessThe inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancerXiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping ChenCancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033
Huang, Mingzhu
- You have accessComparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trialXiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian GuoCancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112
L
Li, Mengyuan
- You have accessPreclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive reviewMengyuan Li, Minghuan Zhang, Qian Ye, Yunhua Liu and Wenbin QianCancer Biology & Medicine September 2023, 20 (9) 646-661; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0202
Li, Wenhua
- You have accessComparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trialXiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian GuoCancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112
Li, Zhan
- You have accessThe inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancerXiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping ChenCancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033
Lin, Yilin
- You have accessBiomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectivesChangjiang Yang, Long Zhao, Yilin Lin, Shan Wang, Yingjiang Ye and Zhanlong ShenCancer Biology & Medicine September 2023, 20 (9) 633-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0201
Liu, Haoyu
- You have accessThe inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancerXiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping ChenCancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033
Liu, Yunhua
- You have accessPreclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive reviewMengyuan Li, Minghuan Zhang, Qian Ye, Yunhua Liu and Wenbin QianCancer Biology & Medicine September 2023, 20 (9) 646-661; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0202
M
Mi, Mi
- You have accessCSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practiceMengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan WengCancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211
P
Pan, Yuefen
- You have accessCSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practiceMengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan WengCancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211
Q
Qian, Wenbin
- You have accessPreclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive reviewMengyuan Li, Minghuan Zhang, Qian Ye, Yunhua Liu and Wenbin QianCancer Biology & Medicine September 2023, 20 (9) 646-661; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0202
Qiu, Lixin
- You have accessComparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trialXiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian GuoCancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112
Qiu, Wei
- You have accessThe inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancerXiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping ChenCancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033
S
Shen, Zhanlong
- You have accessBiomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectivesChangjiang Yang, Long Zhao, Yilin Lin, Shan Wang, Yingjiang Ye and Zhanlong ShenCancer Biology & Medicine September 2023, 20 (9) 633-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0201
Shi, Jie
- You have accessLiquid-liquid phase separation in DNA double-strand break repairJia Chen, Jie Shi, Jian Zheng, Yunlong Wang and Xiangbo WanCancer Biology & Medicine September 2023, 20 (9) 627-632; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0252
Sun, Weijing
- You have accessCSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practiceMengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan WengCancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211
W
Wan, Xiangbo
- You have accessLiquid-liquid phase separation in DNA double-strand break repairJia Chen, Jie Shi, Jian Zheng, Yunlong Wang and Xiangbo WanCancer Biology & Medicine September 2023, 20 (9) 627-632; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0252
Wang, Chenchen
- You have accessComparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trialXiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian GuoCancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112
Wang, Shan
- You have accessBiomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectivesChangjiang Yang, Long Zhao, Yilin Lin, Shan Wang, Yingjiang Ye and Zhanlong ShenCancer Biology & Medicine September 2023, 20 (9) 633-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0201
Wang, Xiaohui
- You have accessThe inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancerXiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping ChenCancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033
Wang, Yunlong
- You have accessLiquid-liquid phase separation in DNA double-strand break repairJia Chen, Jie Shi, Jian Zheng, Yunlong Wang and Xiangbo WanCancer Biology & Medicine September 2023, 20 (9) 627-632; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0252
Weng, Shanshan
- You have accessCSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practiceMengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan WengCancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211
Wu, Zhiqiang
- You have accessThe inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancerXiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping ChenCancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033
X
Xu, Xiang
- You have accessThe inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancerXiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping ChenCancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033
Xu, Ziheng
- You have accessCSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practiceMengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan WengCancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211
Y
Yang, Changjiang
- You have accessBiomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectivesChangjiang Yang, Long Zhao, Yilin Lin, Shan Wang, Yingjiang Ye and Zhanlong ShenCancer Biology & Medicine September 2023, 20 (9) 633-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0201
Yang, Lei
- You have accessComparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trialXiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian GuoCancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112
Yang, Mengyuan
- You have accessCSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practiceMengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan WengCancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211
Ye, Qian
- You have accessPreclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive reviewMengyuan Li, Minghuan Zhang, Qian Ye, Yunhua Liu and Wenbin QianCancer Biology & Medicine September 2023, 20 (9) 646-661; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0202
Ye, Yingjiang
- You have accessBiomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectivesChangjiang Yang, Long Zhao, Yilin Lin, Shan Wang, Yingjiang Ye and Zhanlong ShenCancer Biology & Medicine September 2023, 20 (9) 633-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0201
Yuan, Ying
- You have accessCSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practiceMengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan WengCancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211
Z
Zhang, Minghuan
- You have accessPreclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive reviewMengyuan Li, Minghuan Zhang, Qian Ye, Yunhua Liu and Wenbin QianCancer Biology & Medicine September 2023, 20 (9) 646-661; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0202
Zhang, Wen
- You have accessComparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trialXiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian GuoCancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112
Zhang, Xiaowei
- You have accessComparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trialXiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian GuoCancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112
Zhang, Zhe
- You have accessComparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trialXiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian GuoCancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112
Zhao, Long
- You have accessBiomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectivesChangjiang Yang, Long Zhao, Yilin Lin, Shan Wang, Yingjiang Ye and Zhanlong ShenCancer Biology & Medicine September 2023, 20 (9) 633-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0201
Zhao, Xiaoying
- You have accessComparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trialXiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian GuoCancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112
Zheng, Jian
- You have accessLiquid-liquid phase separation in DNA double-strand break repairJia Chen, Jie Shi, Jian Zheng, Yunlong Wang and Xiangbo WanCancer Biology & Medicine September 2023, 20 (9) 627-632; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0252
Zhu, Xiaodong
- You have accessComparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trialXiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian GuoCancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112
In this issue
